A Phase 3, Randomized, Double Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Natroba™ (spinosad) for the Treatment of Scabies
-
- STATUS
- Recruiting
Summary
Clinical research study for the treatment of scabies.
Description
The main purpose of this study is to compare the safety, efficacy, and tolerability of a once-daily topical application of IDP-123 Lotion compared to the IDP-123 Vehicle Lotion in subjects with moderate to severe acne. Subjects must be at least 9 years of age or older and generally healthy. IDP-123 is a lotion containing 0.045% tazarotene for the topical treatment of acne. “Vehicle” is a term to describe a lotion that does not contain any active drug (similar to a placebo). If you decide to be in this research study, you may receive either the IDP-123 Lotion or the IDP-123 Vehicle Lotion. IDP-123 Lotion is called an investigational drug because it has not been approved for sale by the United States Food and Drug Administration (FDA). Because this is a research study, the topical study drug, IDP-123 Lotion, will be given to you only during this study and not after the study is over.
Assignment to IDP-123 Lotion or IDP-123 Vehicle Lotion will be done randomly, by chance (like tossing a coin). You will have a 50% (1 out of 2) chance of receiving active study lotion and a 50% (1 out of 2) chance of receiving Vehicle Lotion. For this study, all study drug applications will be on the face.
Participation will be approximately 28 days( including 3 in office visits)
You may receive up to $150.00 if you complete the whole study, as a compensation for your time and travel.
Details
| Condition | Family Practice, Dermatology, Seborrheic dermatitis, ATOPIC DERMATITIS, Healthy People 2010 |
|---|---|
| Clinical Study Identifier | TX154533 |
| Last Modified on | 7 November 2020 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer